Medicine Matters diabetes

Advisory Board member Pamela Dyson underlines the key features for healthcare professionals working in diabetes education, diabetes management, type 2 diabetes prevention, and cardiovascular risk reduction.

Editorial Board member Sanjay Kalra presents his view on the march toward greater integration of digital health technologies and how traditional approaches to diabetes management are already changing.

Diabetes and endocrinology Consultant and Advisory Board member Terence Pang highlights the benefits that a structured approach to glycemic goal setting can bring to your practice and patients with type 1 diabetes.

Diabetes nurse consultant and Advisory Board member, Maureen Wallymahmed reflects on her experiences within the profession and charts the evolution of the role over the past 40 years.

Awareness and education about compassion fatigue can help to limit its incidence and severity. Sanjay Kalra outlines strategies to identify and manage the emotional exhaustion that often affects diabetes caregivers.

The drive to achieve lower HbA1c targets in older patients is not without concern or risk. Our UK Board address concerns highlighted by recent trials and discuss whether current guidelines do enough to mitigate the risks of overtreatment.

Formal guidance addressing the optimal use of insulin therapy in diabetic foot ulcer patients is lacking. Editorial Board member Sanjay Kalra and Banshi Saboo present their pragmatic approach to treatment.

Editorial board member John Wilding casts a critical eye over the positive buzz surrounding the potential uses of sodium-glucose cotransporter 2 inhibitors in type 1 diabetes treatment.

Editorial Board member John Wilding highlights the current evidence for the benefits of physical activity across various domains of type 2 diabetes care and prevention, presenting his view of what should be recommended.

Jay Shubrook, Chair of the American Diabetes Association’s Primary Care Advisory Group, outlines what's new in 2018's ADA Standards of Care update. 

Editorial Board member Sanjay Kalra shares his pragmatic and practical suggestions on initiating, monitoring, and titrating suitable patients on U500 regular insulin.

Editorial Board member John Wilding examines what real-world data means to today’s clinicians and presents his vision for the future of this type of evidence.

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of sodium-glucose co-transporter-2 inhibitors in patients affected by acute coronary syndromes.

Should gestational diabetes mellitus be viewed as an opportunity, or an inequality, and should it be a cause for dynamism or despair? Sanjay Kalra and Ankia Coetzee present their perspective on gestational diabetes mellitus.

Advisory Board member and pharmacist, Josh Neumiller, presents a practical guide to support clinical decision-making in the initiation and titration of U300 insulin glargine and insulin degludec.

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of glucagon-like peptide-1 receptor agonists in patients affected by acute myocardial infarction.

In this editorial, Rishi Singh and colleagues provide their perspective on the future of proliferative diabetic retinopathy treatment following the completion of the CLARITY and Protocol S studies.

Editorial Board member John Wilding discusses the place of bariatric surgery in the treatment of type 2 diabetes and whether we should be offering more people surgery as a treatment option in the UK.

Editorial Board member Jay Shubrook and his colleague Alegria Cantillep discuss the National Diabetes Prevention Program, how you might find eligible patients, and how you can refer them to the program.

Treating type 2 diabetes has become so complicated. Why is this so? Primary care physician Jay Shubrook discusses the reasons and suggests ways to make diabetes treatment less overwhelming.